Fáddáevttohusat
Čájehuvvojit 1 - 20 oktiibuot 29 bohtosis ohcui ', ohcanáigi: 0,03s Aiddostahte ozu
  1. 1
    Current directions in the prevention and treatment of Alzheimer's disease

    Current directions in the prevention and treatment of Alzheimer's disease

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Towards developing a universal influenza vaccine

    Towards developing a universal influenza vaccine

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Combating the HIV epidemic

    Combating the HIV epidemic

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    SARS-CoV-2 vaccine development

    SARS-CoV-2 vaccine development

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    The current understanding of the biology of the SARS-COV-2 virus

    The current understanding of the biology of the SARS-COV-2 virus

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    SARS-COV-2 vaccine current biological targets and considerations /

    SARS-COV-2 vaccine current biological targets and considerations /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    SARS-COV-2 what we need to know and possible future therapies /

    SARS-COV-2 what we need to know and possible future therapies /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    SARS-COV-2 vaccine development where are we now? /

    SARS-COV-2 vaccine development where are we now? /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Development of an intranasal vaccine for SARS-CoV-2

    Development of an intranasal vaccine for SARS-CoV-2

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Strategies for exiting the lockdown

    Strategies for exiting the lockdown

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Nanotechnologies in the fight against coronaviruses

    Nanotechnologies in the fight against coronaviruses

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Convalescent plasma therapy as a treatment for COVID-19

    Convalescent plasma therapy as a treatment for COVID-19

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    The development of SARS-CoV-2 vaccines

    The development of SARS-CoV-2 vaccines

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    The evolutionary origin of SARS-CoV-2

    The evolutionary origin of SARS-CoV-2

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Risk of re-emergence of COVID-19 after exit from lockdown

    Risk of re-emergence of COVID-19 after exit from lockdown

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    The COVID-19 coronavirus outbreak October 2020 update /

    The COVID-19 coronavirus outbreak October 2020 update /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Imperial College London's saRNA Vaccine - COVAC1

    Imperial College London's saRNA Vaccine - COVAC1

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

    The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Update on the SNG001 drug, an INFbeta therapy for COVID-19

    Update on the SNG001 drug, an INFbeta therapy for COVID-19

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Human movement patterns and local spread of COVID-19

    Human movement patterns and local spread of COVID-19

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: